文献速递慢性肾脏病肾小球疾病

不同慢性肾脏病病因间近端小管溶质清除率的差异

Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2020-01-01

该研究采用靶向质谱法测定223例门诊慢性肾脏病(CKD)患者11种近端小管分泌溶质的血清和尿液浓度,并按病因分为血管性、糖尿病性、肾小球性和小管间质性。经完全调整后,肾小球疾病相比血管性疾病与三种小管分泌溶质清除率更高相关,糖尿病肾病与异戊酰甘氨酸清除率更高相关。提示不同CKD病因可能对近端小管分泌通路产生不同影响。

要点

  • 肾小球疾病患者三种小管分泌溶质清除率高于血管性疾病患者。
  • 糖尿病肾病仅异戊酰甘氨酸清除率高于血管性疾病。
  • 不同CKD病因对近端小管分泌功能影响存在差异。

核心结论

  • 肾小球疾病和糖尿病肾病相比血管性病因与多种分泌溶质净清除率更高相关。
  • 不同CKD病因可能差异性影响近端小管分泌通路。

研究设计与样本

  • 研究为横断面观察性研究,纳入223例门诊CKD患者。
  • 采用靶向质谱法定量11种近端小管分泌溶质的血清和尿液浓度。
  • 根据临床记录将CKD病因分为血管性、糖尿病性、肾小球性和小管间质性。
  • 采用单因素方差分析比较溶质清除率,错误发现阈值≤5%,并用线性回归校正eGFR、年龄、种族、性别、BMI和尿白蛋白排泄。

主要发现

  • 完全调整后,肾小球疾病相比血管性疾病:异戊酰甘氨酸清除率高48%(95%CI 18-87%),犬尿喹啉酸清除率高28%(95%CI 3-59%),甲基巴豆酰甘氨酸清除率高33%(95%CI 7-67%)。
  • 糖尿病肾病相比血管性疾病:异戊酰甘氨酸清除率高39%(95%CI 13-72%)。

临床怎么用

  • 临床评估CKD时需考虑病因对小管功能的不同影响。
  • 小管分泌溶质清除率可能成为区分CKD病因的潜在指标。
  • 针对不同病因的CKD患者,小管功能监测策略可能需个体化。

局限性

  • 研究为横断面设计,无法推断因果关系。
  • 样本量有限(223例),可能影响亚组分析效能。
  • 仅评估11种分泌溶质,不能全面反映小管功能。
  • 病因分类基于临床记录,可能存在误分类偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laboratory measures of glomerular function such as the glomerular filtration rate (GFR) contribute toward clinical evaluation of chronic kidney disease (CKD). However, diverse CKD etiologies have distinct pathological mechanisms that may differentially impact the kidney tubules. Little is known regarding how tubular function changes with varying kidney disease types. METHODS: We used targeted mass spectrometry to quantify paired serum and urine concentration of 11 solutes of proximal tubular secretion in 223 patients from an outpatient CKD cohort. We reviewed clinic notes to ascertain the primary CKD diagnosis and categorized these as vascular, diabetic, glomerular or tubulointerstitial. We used one-way analysis of variance to compare secretory solute clearance across diagnoses setting a false discovery threshold of ≤5% and used linear regression to compare differences after adjustments for estimated GFR, age, race, sex, body mass index and urine albumin excretion. RESULTS: After full adjustment, glomerular disease was associated with higher clearances of three tubular secretory solutes compared with vascular disease: 48% higher isovalerylglycine clearance [95% confidence interval (CI) 18-87%], 28% higher kynurenic acid clearance (95% CI 3-59%) and 33% higher tiglylglycine clearance (95% CI 7-67%). Diabetic kidney disease (DKD) was associated with 39% higher isovalerylglycine clearance compared with vascular disease (95% CI 13-72%). CONCLUSION: Glomerular disorders and DKD are associated with higher net clearances of several secretory solutes compared with vascular causes of kidney disease. These findings suggest that different underlying etiologies of CKD may differentially impact proximal tubular secretory pathways.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wang K, Zelnick LR, Hoofnagle AN, et al. Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease. Nephrol Dial Transplant. 2020. PMID: 31347660. doi:10.1093/ndt/gfz144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。